Details of the Drug Formulations

General Information of Drug (ID: DMR7IVC)

Drug Name
Pimavanserin Drug Info
Synonyms ST51054136; AC-5273; I14-1981; 1-[(4-fluorophenyl)methyl]-1-(1-methyl-4-piperidyl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
Indication
Disease Entry ICD 11 Status REF
Parkinson disease 8A00.0 Approved [1]
Cross-matching ID
PubChem CID
10071196
ChEBI ID
CHEBI:133017
CAS Number
706779-91-1
TTD ID
D0J8JP
ACDINA ID
D00531

Full List of Drug Formulations Containing This Drug

Pimavanserin 17 mg tablet
Company Formulation ID FDA Description
ACADIA Pharmaceuticals F17266 Saccharin sodium anhydrous; Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 3350; Hypromellose 2910 (15 mpa.s); Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------
Pimavanserin Tartrate 10 mg tablet
Company Formulation ID FDA Description
Acadia Pharmaceuticals F23516 Magnesium Stearate; Pregelatinized Starch; Silicified Microcrystalline Cellulose; Polyethylene Glycol; Polyvinyl Alcohol; Red Iron Oxide; Talc; Titanium Dioxide; Yellow Iron Oxide
------------------------------------------------------------------------------------
Pimavanserin Tartrate 34 mg capsule
Company Formulation ID FDA Description
Acadia Pharmaceuticals F23515 Magnesium Stearate; Microcrystalline Cellulose; Black Iron Oxide; Fd&C Blue 1; Hypromellose; Titanium Dioxide; Yellow Iron Oxide
------------------------------------------------------------------------------------

References

1 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.